Occupational therapy in oncology palliative care for adolescents and young adults: Perspectives of Australian occupational therapists, Amy Wallis, Pamela Meredith, Mandy Stanley
Research outputs 2022 to 2026

Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer, Emmanuel Acheampong, Afaf Abed, Michael Morici, Isaacs Spencer, Aaron B. Beasley, Samantha Bowyer, Du Bois Asante, Chris Lomma, Weitao Lin, Michael Millward, Elin S. Gray
Research outputs 2022 to 2026

Conventional therapies deplete brain-Infiltrating adaptive immune cells in a mouse model of group 3 medulloblastoma implicating myeloid cells as favorable immunotherapy targets, Zahra Abbas, Courtney George, Mathew Ancliffe, Meegan Howlett, Anya C. Jones, Mani Kuchibhotla, Robert J. Wechsler-Reya, Nicholas G. Gottardo, Raelene Endersby
Research outputs 2022 to 2026

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 3 – spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers, Albert Stuart Reece, Gary Kenneth Hulse
Research outputs 2022 to 2026

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 2 – categorical bivariate analysis and attributable fractions, Albert Stuart Reece, Gary Kenneth Hulse
Research outputs 2022 to 2026

PD-L1 expression on circulating tumor cells may be predictive of response to Pembrolizumab in advanced melanoma: Results from a pilot study, Muhammad K. Khattak, Anna L. Reid, James Freeman, Michelle Pereira, Ashleigh McEvoy, Johnny Lo, Markus Frank, Tarek Meniawy, Ali Didan, Isaac Spencer, Benhur Amanuel, Michael Millward, Mel Ziman, Elin Gray
Research outputs 2014 to 2021

Characterising PD-L1 expression in circulating melanoma and non-small cell lung cancer cells, Isaac Spencer
Theses: Doctorates and Masters

Is the blood an alternative for programmed cell death ligand 1 assessment in non-small cell lung cancer?, Emmanuel Acheampong, Isaac Spencer, Weitao Lin, Melanie Ziman, Michael Millward, Elin Gray
Research outputs 2014 to 2021

Genetic markers in circulating tumour cells as a measure of the metastatic propensity of uveal melanoma, Aaron Beasley
Theses: Doctorates and Masters

Autoantibody production in cancer—The humoral immune response toward autologous antigens in cancer patients, Pauline Zaenker, Elin Solomonovna Gray, Melanie Ruth Ziman
Research outputs 2014 to 2021

Investigating the role of Dachshund Homolog 1 (DACH1) and miR-200b in Group 4 medulloblastoma pathogenesis, Courtney George
Theses : Honours

A very rare cancer in Down syndrome: Medulloblastoma. Epidemiological data from 13 countries, Daniel Satge, Charles Stiller, Stefan Rutkowski, Andre von Bueren, Brigitte Lacour, Daniele Sommelet, Motoi Nishi, Maura Massimino, Maria Luisa Garre, Florencia Moreno, Henrik Hasle, Zsuzsanna Jakab, Mark Greenberg, Nicolas von der Weid, Claudia Kuehni, Oscar Zurriaga, Maria-Luisa Vincente, Rafael Peris-Bonet, Martin Benesch, Michel Vekemans, Sheena G. Sullivan, Christian Rickert
Research outputs 2013

Overexpression of hCLP46 enhances Notch activation and regulates cell proliferation in a cell type-dependent manner, Q Chu, L Liu, Wei Wang
Research outputs 2013

Validation and Development of N-glycan as Biomarker in Cancer Diagnosis, Wei Wang
Research outputs 2013

Heat stress: A risk factor for skin carcinogenesis [journal article], Leslie D. Calapre, Elin S. Gray, Melanie R. Ziman
Research outputs 2013